LY9 and type 2 diabetes mellitus: This finding is significant to understand the mechanisms by which palmitic acid promotes inflammation in patients with type 2 diabetes, which show the upregulation of SLAMF3 on T cells compared with healthy persons, and SLAMF3 has been associated with increased production of pro-inflammatory cytokines.